 asymptomatic patients was conﬁrmed by the longterm results of the ACST, as reported by Halliday et al.23
That trial had compared CEA and a medical arm, in which
patients had primarily received antithrombotic and antihypertensive therapy. The results showed that the CEA
arm (patients aged <75 years) experienced signiﬁcantly
lower perioperative and 10-year stroke rates (13.3%